Stefan R. Bornstein | |
---|---|
Director of the Centre for Internal Medicine and the Medical Clinic and Policlinic III at the University Hospital Carl Gustav Carus Dresden, Germany | |
Personal details | |
Born | Oberstdorf, Germany | 5 November 1961
Nationality | German |
Alma mater | University of Ulm |
Occupation | Physician |
Stefan R. Bornstein (November 5, 1961 in Oberstdorf, Germany) is the director of the Centre for Internal Medicine and the Medical Clinic and Policlinic III at the University Hospital Carl Gustav Carus [1] of the Technical University of Dresden as well as the medical faculty's vice dean of international affairs and development and a member of the supervisory board of the University Hospital of Dresden. Furthermore, he is chair and honorary consultant for diabetes and endocrinology at King's College London. [2] Previously, Bornstein worked as assistant director and professor of endocrinology at the University Hospital of Düsseldorf, as unit chief at the National Institutes of Health in Bethesda, Maryland and held the Heisenberg-scholarship of the Deutsche Forschungsgemeinschaft.
Bornstein is known primarily for his pioneering work on the stress system. He was the first to investigate the interactions of the two central stress hormones adrenaline and cortisol in healthy as well as sick individuals in close collaboration with Nobel Prize laureates such as Andrew V. Schally [3] and Rita Levi Montalcini [4] Recently, Bornstein co-developed new therapeutic approaches to diabetes in preclinical and clinical stages. He has authored more than 500 publications and textbook articles with more than 12,000 citations, [5] won numerous prizes and holds honorary professorships at universities in Europe, Asia and the USA. He is a member of the German Science Association (Deutsche Forschungsgemeinschaft) [6] and the German Academy of Sciences, Leopoldina (Deutsche Akademie der Wissenschaften) [7] 2018 he received the order of merit of the first class of Germany (Bundesverdienstkreuz 1 Klasse) from the President Frank Walter Steinmeier.
Bornstein was born in Oberstdorf, Germany, in 1961 as one of four siblings. His parents were textile merchants (Stoffversand Bornstein). In the late 19th century, the Bornstein family emigrated to the United States, only to return to Germany shortly before World War I in which Stefan R. Bornstein's grandfather was honored with the Iron Cross. During the Nazi regime, many members of the Bornstein family both from the father's and mother's side were persecuted. Stefan R. Bornstein's grandfather, Max Bornstein, survived the Theresienstadt concentration camp but died shortly after World War II. Other relatives fled to England or the USA. Richard Lindner, an uncle of Bornstein's became a famous painter in the US and a trailblazer of American Pop-Art. A cousin married into the Belgian royal house, becoming Princess Léa of Belgium. His grandmother on the maternal side Rosa Haas was a famous Opera star in Vienna. The international background of the family and the travelling required for their textile business introduced Bornstein to different cultures and languages at a young age. Professor Stefan R. Bornstein has two sons and was married to Monica Ehrhart-Bornstein, a well-known neurobiologist and molecular endocrinologist. She died in October 2015. Stefan got married again and he has one daughter from his second marriage.
Bornstein took his German Abitur at the Gertrud-von-le-Fort-Gymnasium in Oberstdorf as class winner and studied medicine at the University of Ulm/Germany from 1982 to 1988. He did his practical year at the University of Miami, US, supervised by Maxwell McKenzie. In addition to his German state examination he holds the American Medical Licence ECFMG as well as the British license to practice medicine GMC-UK. He did his residency at the University Hospital Ulm under Ernst-Friedrich Pfeiffer and Professor Guido Adler during which he had a short research internship at the Biochemistry Department of the South West Medical Center, University of Texas, US, with Michael Waterman. 1994 he earned his Certificate of Completion of Training of internal medicine and in 1996 the sub-specialization of Endocrinology and Diabetology. From 1994 to 1997 he had an assistant professorship at the Department for Internal Medicine at the University of Leipzig with Werner Scherbaum. In 1995 he received his state doctorate in cooperation with the IZKF at the University of Leipzig. From 1996 to 1997 and 1998 to 1999 he held the Heisenberg-scholarship of the German Science Association; later he became unit chief under Prof. George P. Chrousos at the National Institutes of Health.
From 2001 to 2004 Bornstein held a C3-Professorship and was assistant director of the Department of Endocrinology and Metabolism at the University of Düsseldorf. From 2000 to 2002 he was scientific coordinator of a NIH-state-of-the-science-conference on adrenal tumors. In 2002 he was offered the directorship for internal medicine at the University of Adelaide and the Bo Schembechler Chair of Medicine at the University of Michigan, Ann Arbor, US, which he declined. Since 2004 he has held a C4-Professorship and directorship of the Department for Internal Medicine in Dresden. Furthermore, he became member of the Max Planck Graduate School in 2004 and is founding and board member of the excellence cluster Center for Regenerative Therapies Dresden (CRTD). In 2008 he became honorary professor at the University of Miami. Together with Julio Licinio he founded the German Australian Institute of Translational Medicine (GAITM) [8] in 2009. Since 2011 he has been a consultant at the John Curtin School of Medical Research in Canberra and a board member of the John Curtin Medical Research Foundation. He has been an honorary professor at the Hong Kong University since 2012 [9] and a professor and honorary consultant at King's College London since 2013.
Bornstein's scientific focus lies on the adrenal gland as on organ of stress, stem cell research and advances in islet cell transplantation as a therapy for diabetes. This is why, presently, Dresden is the only active German center of this treatment. Since 2011 Bornstein has been spokesman for the research group KFO 252 of the German Science Association (Deutsche Forschungsgemeinschaft DFG) [10] and one of the coordinators of the Paul-Langerhans-Institute Dresden. Since 2012, he has been scientific secretary of the DFG Transregio 127. [11] Main research areas are: endocrinology and internal medicine (e.g. adrenal gland, stress, and stem cell research), diabetes, transplant medicine (e.g. new strategies to improve diabetes treatment), public healthcare and preventive medicine (prevention of diabetes)
Bornstein is chief of the medical clinic and policlinic III (Medizinische Klinik und Poliklinik III) at the university hospital Carl Gustav Carus in Dresden, which is a major centre of treatment and research of diabetes mellitus type I and type II in Europe as well as its sequelae, like the diabetic foot syndrome, heart and blood vessel diseases and diabetic nephropathy. A major topic is creating individual treatment strategies to prevent the increase in diabetes prevalence. That is why in 2009 they created the first professorship for diabetes prevention in Germany. In 2008 started the only currently active program of islet transplantation in Germany. This treatment is a great benefit for patients with diabetes type I with great deviations in their glucose blood levels. Recent research includes a bioreactor of insulin-producing cells in a small implantable chamber which offers an immunoisolation, making the implantation possible without immune suppressive therapy. [12]
Endocrinology is a branch of biology and medicine dealing with the endocrine system, its diseases, and its specific secretions known as hormones. It is also concerned with the integration of developmental events proliferation, growth, and differentiation, and the psychological or behavioral activities of metabolism, growth and development, tissue function, sleep, digestion, respiration, excretion, mood, stress, lactation, movement, reproduction, and sensory perception caused by hormones. Specializations include behavioral endocrinology and comparative endocrinology.
TU Dresden, also as the Dresden University of Technology, is a public research university in Dresden, Germany. It is the largest institute of higher education in the city of Dresden, the largest university in Saxony and one of the 10 largest universities in Germany with 32,389 students as of 2018.
The German Research Foundation is a German research funding organization, which functions as a self-governing institution for the promotion of science and research in the Federal Republic of Germany. In 2019, the DFG had a funding budget of €3.3 billion.
Zvi Laron is an Israeli paediatric endocrinologist. Born in Cernăuţi, Romania, Laron is a professor emeritus at Tel Aviv University. In 1966, he described the type of dwarfism later called Laron syndrome. His research opened the way to the treatment of many cases of growth hormone disorders. He was the first to introduce the multidisciplinary treatment for juvenile diabetes.
Dr. A. M. James Shapiro is a British-Canadian surgeon best known for leading the clinical team that developed the Edmonton Protocol – an islet transplant procedure for the treatment of type 1 diabetes. Dr. Shapiro is Professor of Surgery, Medicine, and Surgical Oncology at the University of Alberta and the Director of the Clinical Islet Transplant Program and the Living Donor Liver Transplant Program with Alberta Health Services.
The Gottfried Wilhelm Leibniz Prize, or Leibniz Prize, is awarded by the German Research Foundation to "exceptional scientists and academics for their outstanding achievements in the field of research". Since 1986, up to ten prizes have been awarded annually to individuals or research groups working at a research institution in Germany or at a German research institution abroad. It is considered the most important research award in Germany.
Islet transplantation is the transplantation of isolated islets from a donor pancreas into another person. It is a treatment for type 1 diabetes. Once transplanted, the islets begin to produce insulin, actively regulating the level of glucose in the blood.
Paul Eston Lacy was an anatomist and experimentalist and one of the world’s leading diabetes mellitus researchers. He is often credited as the originator of islet transplantation.
George P. Chrousos is professor of Pediatrics and Endocrinology Emeritus and former chairman of the Department of Pediatrics at the Athens University Medical School, Greece. Earlier he was senior investigator, director of the Pediatric Endocrinology Section and Training Program, and chief of the Pediatric and Reproductive Endocrinology Branch of the National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH). He is also clinical professor of Pediatrics, Physiology and Biophysics at Georgetown University Medical School and distinguished visiting scientist, NICHD, NIH. Dr. Chrousos was the first general director of the Foundation of Biomedical Research of the Academy of Athens (2001–2002). He holds the UNESCO Chair on Adolescent Health Care, while he held the 2011 John Kluge Chair in Technology and Society, Library of Congress, Washington, D.C.
Roland Benz is a German biophysicist.
Bernhard J. Hering is professor of surgery and medicine and executive director of the Schulze Diabetes Institute at the University of Minnesota, where he serves as Vice Chair of Translational Medicine in the Medical School's Department of Surgery and where he holds the McKnight Presidential Chair in Transplantation Science and the Jeffrey Dobbs and David Sutherland, MD, PhD Chair in Diabetes Research.
Gunther Hartmann is a German immunologist and clinical pharmacologist. Since 2007 he has been the Director of the Institute of Clinical Chemistry and Clinical Pharmacology at the University Hospital of the University of Bonn.
Paolo Brenner is a German physician and a professor of cardiac surgery at the Department of Cardiac Surgery, Klinikum Großhadern of the Ludwig Maximilian University of Munich (LMU). He is known for his work in the fields of xenotransplantation, the advancement of artificial hearts, extracorporeal membrane oxygenation (ECMO) and lung transplantation.
Matthias H. Tschöp is a German physician and scientist. He is the chief executive officer and scientific director of Helmholtz Zentrum München, German Research Center for Environmental Health. He is also Alexander von Humboldt Professor and chair of metabolic diseases at Technical University of Munich and serves as an adjunct professor at Yale University.
Katja Becker is a German physician and biochemist who has been serving as the president of the German Research Foundation (DFG) since 2020. She had previously been the organization's vice president from 2014 to 2019.
Camillo Ricordi is a diabetes researcher based in Miami, Florida. He currently serves as Director of the Diabetes Research Institute, a position he has held since 1996. He is the Chief Academic Officer of the Diabetes Research Institute of the University of Miami and is director of the DRI's Cell Transplant Center. He has been active in stem cell research and its applications to treating diabetes, particularly Type 1 Diabetes. He specializes in pancreatic islet transplantation.
Michael Roden is Professor and Chairman of Internal Medicine, Endocrinology and Metabolic Disorders at Heinrich Heine University Düsseldorf, Director of the Division of Endocrinology and Diabetology at the University Hospital of Düsseldorf and Spokesman for the Executive Board and Scientific Director of the German Diabetes Center, the Leibniz Center for Diabetes Research at the Heinrich Heine University Düsseldorf.
The German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at Heinrich Heine University (HHU), is a research institution based in Düsseldorf. In 1964, it was founded due to the initiative of Prof. Dr. med. Karl Oberdisse as an Association for the Promotion of Research on Diabetes mellitus. The DDZ performs research on diabetes mellitus in a transdisciplinary approach. The aim is the prevention, early detection, diagnosis and treatment of diabetes and its sequelae. The work focuses on application-oriented research in the fields of clinical diabetology, clinical biochemistry and pathobiochemistry, biometrics and epidemiology, vascular and islet cell biology as well as health services research and health economics. The investigation of risk genes, mechanisms, individual lifestyles in combination with environmental influences and their long-term effects on the population and their supply play a decisive role. DDZ has also performed clinical studies and established several cohorts, such as the German Diabetes Study (GDS), which examines the course of diabetes as well as its sequelae. Since 2008, Michael Roden is the chief scientific officer and spokesman of the board of the DDZ as well as the director of the Institute for Clinical Diabetology. Additionally, he serves as the chief physician of the Division of Endocrinology and Diabetology at the University Hospital Düsseldorf.
Wiebke Arlt is a German endocrinologist. She is Director of the MRC London Institute of Medical Sciences and Head of the Institute of Clinical Sciences at Imperial College London. She is also Honorary Professor at the University of Birmingham. She specialises in adrenal disease and disorders of sex development.
Hermann Christof Einsele is a German hematologist and oncologist and professor at the Julius Maximilians University of Würzburg.